GO:0002764 immune response-regulating signaling pathway: Signaling Cascade, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0002764 (immune response-regulating signaling pathway) describes the receptor-to-second-messenger cascade that activates, sustains, or inhibits an immune response [1,6].
• The term is a biological_process that sits upstream of effector immune programs and is distinct from the immune response itself.
• Toll-like receptor (TLR) signaling, especially TLR2 and TLR4, is a canonical example of this process in innate immunity [1,6].
• Deregulation of immune response-regulating signaling is linked to fulminant hepatitis in pregnancy, periapical lesions, pulmonary fibrosis, and primary biliary cholangitis [3,4,5,8].
• Key nodes include TLR2, TLR4, MYD88, NFKB1, TNF, IL6, and interferon-related effectors that convert receptor signals into transcriptional outputs [1,3,6].
• CRISPR knockout, point-mutation, knock-in, and overexpression models allow causal testing of each signaling node in immune cells and organoid systems [2,5,8].
Description
GO:0002764, immune response-regulating signaling pathway, is a Gene Ontology biological_process defined as the cascade of processes by which a signal interacts with a receptor, causing a change in the level or activity of a second messenger or other downstream target, and ultimately leading to the activation, perpetuation, or inhibition of an immune response. In practical terms, it is the molecular relay that converts an extracellular or intracellular immune cue into a coordinated cellular response [1,6]. This term is central to immunology because it separates the signaling machinery from the downstream effector functions it controls, allowing researchers to dissect how immune responses are initiated, amplified, or restrained [1,6]. Experimental work has shown that serum-borne lipids can amplify TLR-activated inflammatory responses, demonstrating that the same receptor-proximal cascade can be tuned by the metabolic microenvironment. Similarly, TLR2-mediated signaling networks are recognized as a maze of interconnected adaptors and kinases that determine the outcome of mycobacterial infection control. These examples illustrate why GO:0002764 is not a single linear pathway but a modular system that integrates multiple inputs. From a disease perspective, deregulation of immune response-regulating signaling has been associated with fulminant hepatitis in HEV-infected pregnant women, oral periapical lesion progression, pulmonary fibrosis, and primary biliary cholangitis [3,4,5,8]. Understanding the genes and mechanisms within GO:0002764 therefore has direct translational relevance for biomarker discovery and therapeutic targeting [2,3,8].
immune response-regulating signaling pathway At A Glance
| GO ID | GO:0002764 |
|---|---|
| GO term | immune response-regulating signaling pathway |
| Ontology | biological_process |
| Synonym | immune response-regulating signalling pathway |
| Definition | The cascade of processes by which a signal interacts with a receptor, causing a change in the level or activity of a second messenger or other downstream target, and ultimately leading to the activation, perpetuation, or inhibition of an immune response. |
| Major function | Transduce receptor-proximal signals into second-messenger and transcriptional outputs that activate, sustain, or inhibit immune responses [1,6]. |
| Representative receptors | Toll-like receptors including TLR2 and TLR4 [1,6]. |
| Representative downstream nodes | MYD88, NFKB1, TNF, IL6, and interferon-related effectors [1,3,6]. |
| Disease relevance | Fulminant hepatitis, periapical lesions, pulmonary fibrosis, and primary biliary cholangitis [3,4,5,8]. |
What Is GO:0002764?
In our own words, GO:0002764 describes the entire sequence of molecular events that begins when a signal engages a receptor and ends with a change in the activity or abundance of a second messenger or downstream target, with the ultimate consequence being activation, maintenance, or suppression of an immune response. It is a biological_process term, meaning it describes a dynamic program rather than a static component or a single molecular function [1,6].
Why Is immune response-regulating signaling pathway Important in Cell Biology?
GO:0002764 is important because it defines the regulatory layer that determines whether an immune response is launched, maintained, or shut down. Many human diseases are driven not by a missing immune effector but by a misregulated signaling relay, making this term a focal point for mechanistic studies and therapeutic intervention [1,3,6,8].
• Provides a framework for dissecting how receptor-proximal signals control immune activation versus tolerance [1,6].
• TLR2 and TLR4 signaling are canonical examples and are targeted in mycobacterial infection research [1,6].
• Serum-borne lipids can amplify TLR-activated inflammatory responses, linking metabolism to this pathway.
• Deregulation of immune response-regulating signaling contributes to fulminant hepatitis in HEV-infected pregnant women.
• The pathway is implicated in oral periapical lesion formation and progression.
• Single-cell studies identify immune cell types enhanced in pulmonary fibrosis, a disease with altered immune signaling.
• Primary biliary cholangitis shows strong HLA and non-HLA risk loci in immune response genes.
• Bioinformatics predictors of arteriovenous fistula maturation highlight immune signaling as a clinical variable.
• The pathway is a rich source of candidate drug targets and biomarkers for inflammatory disease [1,3,8].
• CRISPR-based models enable causal validation of individual nodes within the cascade [2,5,8].
What Happens During immune response-regulating signaling pathway?
Receptor engagement and signal initiation
In simple terms: A signal molecule docks onto a receptor on the immune cell surface, starting the relay.
The first step of GO:0002764 is the interaction of a signal with its receptor, which triggers conformational changes and recruitment of proximal adaptors. In TLR biology, this step is exemplified by TLR2 and TLR4 sensing microbial or endogenous ligands and initiating intracellular signaling [1,6]. The nature of the ligand and the receptor context determines whether the downstream outcome is inflammatory or regulatory.
Second messenger generation and amplification
In simple terms: The receptor signal is converted into small intracellular messengers that amplify the message.
Following receptor engagement, second messengers and kinase cascades amplify the initial signal. Serum-borne lipids have been shown to amplify TLR-activated inflammatory responses, indicating that the second-messenger environment can be modulated by systemic factors. This amplification step is a key control point because it determines the magnitude and duration of the eventual immune response [1,6].
Adaptor and kinase network integration
In simple terms: A network of adaptor proteins and kinases integrates multiple inputs before passing the signal forward.
The TLR2-mediated signaling network is described as a maze of interconnected adaptors and kinases that shape the outcome of infection control. Integration at this level allows the cell to weigh competing signals and decide whether to activate, perpetuate, or inhibit an immune response, consistent with the GO:0002764 definition.
Transcriptional and effector output
In simple terms: The signal reaches the nucleus and switches on or off immune response genes.
The terminal phase of GO:0002764 involves changes in transcription factors such as NFKB1 and the production of cytokines including TNF and IL6, which execute the immune response [1,3,6]. In HEV-infected pregnant women, deregulation of immune response pathways contributes to fulminant hepatitis, illustrating how transcriptional output from this cascade can become pathogenic.
Resolution and inhibition
In simple terms: The pathway also includes brakes that shut the immune response down once the threat is controlled.
The GO:0002764 definition explicitly includes inhibition of an immune response, meaning negative regulators and feedback loops are integral to the process [1,6]. Loss of these inhibitory arms can lead to chronic inflammation, as seen in diseases such as pulmonary fibrosis and primary biliary cholangitis where immune signaling is persistently altered [5,8].
Key Genes Involved in GO:0002764 immune response-regulating signaling pathway
The following genes and proteins are representative nodes within GO:0002764, spanning receptors, adaptors, transcription factors, and effector cytokines.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TLR2 | Receptor that initiates immune response-regulating signaling in response to microbial ligands | Central to mycobacterial infection control studies |
| TLR4 | Receptor that activates inflammatory signaling upon ligand engagement | Target for studying lipid-amplified inflammation |
| MYD88 | Proximal adaptor that relays TLR signals to downstream kinases | Key node for dissecting TLR2-mediated networks |
| NFKB1 | Transcription factor that drives expression of immune response genes [1,3] | Readout of pathway activation in hepatitis and inflammation models |
| TNF | Effector cytokine produced downstream of immune signaling [1,3] | Biomarker and functional output in inflammatory disease |
| IL6 | Cytokine that amplifies and perpetuates immune responses [1,3] | Measured in TLR-activated inflammatory assays |
| IFNG | Interferon that shapes immune response-regulating signaling outcomes | Studied in viral hepatitis and immune deregulation |
| HLA-DRB1 | Antigen presentation component linked to immune response regulation | Risk locus in primary biliary cholangitis |
| IL12A | Cytokine that influences immune signaling balance | Non-HLA risk locus in primary biliary cholangitis |
| IL12RB2 | Receptor for IL12 that modulates immune signaling | Associated with autoimmune cholangitis risk |
| STAT4 | Transcription factor downstream of cytokine receptors | Immune signaling risk locus in cholangitis |
| IRF5 | Interferon regulatory factor involved in immune signaling | Non-HLA risk locus in primary biliary cholangitis |
| CD40 | Costimulatory receptor that regulates immune signaling | Risk locus in autoimmune disease |
| CXCR5 | Chemokine receptor influencing immune cell positioning | Studied in pulmonary fibrosis immune cell analysis |
| CCR2 | Chemokine receptor that regulates monocyte recruitment | Relevant to immune cell types enhanced in fibrosis |
| S100A8 | Alarmin that modulates inflammatory signaling | Associated with periapical lesion progression |
| S100A9 | Alarmin partner of S100A8 in inflammatory signaling | Studied in oral periapical lesions |
| MMP9 | Effector enzyme downstream of immune signaling | Marker of tissue remodeling in periapical lesions |
How Is immune response-regulating signaling pathway Regulated?
GO:0002764 is regulated at multiple levels. Serum-borne lipids can amplify TLR-activated inflammatory responses, showing that systemic metabolic factors modulate the pathway. The TLR2-mediated signaling network contains numerous positive and negative regulators that determine infection outcome. In disease contexts, deregulation of immune response pathways in HEV-infected pregnant women and altered immune signaling in primary biliary cholangitis demonstrate that host genetic and physiological states can shift the balance of activation versus inhibition [3,8].
immune response-regulating signaling pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TLR2 | Mycobacterial infection control | Knockout macrophage model with mycobacterial challenge |
| TLR4 | Lipid-amplified inflammation | Overexpression in immune cells with lipid treatment |
| IFNG | Fulminant hepatitis in HEV-infected pregnancy | Knockout hepatocyte or immune cell model |
| IL12A | Primary biliary cholangitis | Knock-in of risk variant in cholangiocyte model |
| S100A8 | Oral periapical lesion progression | Knockout in oral epithelial or immune cells |
Immune signaling deregulation in viral hepatitis
Deregulation of immune response contributing to fulminant hepatitis in HEV-infected pregnant women highlights how altered immune response-regulating signaling can lead to severe liver injury. The study points to immune pathway dysregulation as a driver of disease severity rather than a secondary consequence.
Immune signaling in oral periapical lesions
Integrated metagenomics and transcriptomics analysis reveals pathways associated with oral periapical lesions formation and progression, implicating immune response-regulating signaling in the pathogenesis of these lesions. Genes such as S100A8, S100A9, and MMP9 are among the effectors linked to this process.
Immune cell types in pulmonary fibrosis
Multiplatform single-cell analysis identifies immune cell types enhanced in pulmonary fibrosis, providing a cellular map of altered immune signaling in fibrotic lung disease. Chemokine receptors such as CXCR5 and CCR2 are relevant to the immune cell composition observed.
Genetic architecture of primary biliary cholangitis
Genetic architecture of primary biliary cholangitis shows strong evidence for HLA and non-HLA risk loci, many of which are immune response genes such as IL12A, IL12RB2, STAT4, IRF5, and CD40. This supports a model in which inherited variation in immune response-regulating signaling contributes to autoimmune cholangitis.
From immune response-regulating signaling pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of TLR2 alter mycobacterial control? | TLR2 knockout in macrophages |
| Does a risk variant in IL12A change immune signaling? | IL12A point-mutation knock-in in cholangiocytes |
| Can lipid exposure amplify TLR4-driven inflammation? | TLR4 overexpression with lipid treatment |
| Which immune cell types drive pulmonary fibrosis? | Single-cell profiling of knockout and wild-type models |
| Does S100A8 deletion reduce periapical lesion progression? | S100A8 knockout in oral lesion model |
| Can tagging a signaling node reveal its interactome? | Tagged knock-in of MYD88 or NFKB1 |
How to Study the immune response-regulating signaling pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global transcript changes downstream of immune signaling [3,4] | Identifying immune response pathways in disease tissue [3,4] |
| Single-cell RNA-seq | Immune cell type composition and states | Mapping immune cells in pulmonary fibrosis |
| Bioinformatics pathway analysis | Enrichment of immune signaling gene sets [2,4] | Predicting clinical outcomes and lesion progression [2,4] |
| Cytokine ELISA | TNF and IL6 protein levels | Measuring TLR-activated inflammatory responses |
| Flow cytometry | Immune cell activation markers | Validating cell-type-specific signaling changes |
| Metagenomics | Microbial composition associated with lesions | Linking microbes to immune signaling in periapical lesions |
| Genetic association analysis | HLA and non-HLA risk loci | Identifying immune signaling variants in cholangitis |
Transcriptomic profiling of immune signaling
RNA-seq and integrated transcriptomics can map the gene expression changes downstream of GO:0002764. Studies of oral periapical lesions and HEV-infected pregnant women used transcriptomic approaches to identify immune response pathways associated with disease [3,4].
Single-cell analysis of immune cell types
Multiplatform single-cell analysis identifies immune cell types enhanced in pulmonary fibrosis, allowing researchers to resolve which cell populations are driving altered immune signaling. This method is valuable for linking GO:0002764 activity to specific immune subsets.
Bioinformatics and pathway prediction
Bioinformatics approaches can identify predictors of clinical outcomes such as arteriovenous fistula maturation, highlighting immune signaling variables. Pathway enrichment and network analysis are commonly used to interpret GO:0002764-related gene lists [2,4].
Functional assays of TLR signaling
TLR-activated inflammatory responses can be measured in vitro using cytokine readouts such as TNF and IL6, and these assays can be combined with lipid treatment to test amplification effects. Such functional assays are essential for validating findings from transcriptomic studies [1,6].
How CRISPR Can Be Used to Study GO:0002764 immune response-regulating signaling pathway
Knockout
CRISPR knockout of genes such as TLR2, MYD88, or NFKB1 can test whether a specific node is required for immune response-regulating signaling. Knockout models are particularly useful for dissecting the TLR2-mediated signaling network in infection control.
Point Mutation
Point-mutation models can introduce disease-associated variants in immune signaling genes such as IL12A or STAT4 to test their functional impact on GO:0002764. This approach helps distinguish causal variants from bystander associations in primary biliary cholangitis.
Knock-in
Knock-in of tagged or reporter alleles at loci like MYD88 or NFKB1 allows real-time tracking of signaling dynamics and interactome mapping. Knock-in models are also valuable for studying risk loci identified in genetic studies of immune-mediated disease.
Overexpression
Overexpression of TLR4 or downstream effectors can amplify immune response-regulating signaling and model chronic inflammatory states. Such models are useful for testing whether lipid or metabolic factors further amplify the pathway.
How EDITGENE Supports immune response-regulating signaling pathway Research
Researchers studying immune response-regulating signaling pathway-related genes often need to determine whether a candidate gene is causally involved in immune activation, perpetuation, or inhibition. EDITGENE provides the CRISPR tools and bioinformatics support to move from association to mechanism.
Contact EDITGENE today to design your custom CRISPR model for immune response-regulating signaling pathway research.
Frequently Asked Questions About immune response-regulating signaling pathway
What is GO:0002764 immune response-regulating signaling pathway?
GO:0002764 is a Gene Ontology biological_process describing the cascade by which a signal interacts with a receptor, changes second-messenger or downstream target activity, and ultimately activates, perpetuates, or inhibits an immune response [1,6].
What genes are involved in immune response-regulating signaling pathway?
Representative genes include TLR2, TLR4, MYD88, NFKB1, TNF, IL6, IFNG, IL12A, IL12RB2, STAT4, IRF5, and CD40 [1,3,6,8].
How is immune response-regulating signaling pathway related to TLR2?
TLR2 is a receptor that initiates immune response-regulating signaling, and the TLR2-mediated signaling network is a well-studied example of this process.
What diseases are linked to GO:0002764?
Deregulation of this pathway has been linked to fulminant hepatitis in HEV-infected pregnant women, oral periapical lesions, pulmonary fibrosis, and primary biliary cholangitis [3,4,5,8].
Can serum lipids affect immune response-regulating signaling?
Yes, serum-borne lipids can amplify TLR-activated inflammatory responses, showing that metabolic factors modulate this pathway.
What methods are used to study immune response-regulating signaling pathway?
Common methods include RNA-seq, single-cell RNA-seq, cytokine ELISA, flow cytometry, metagenomics, and bioinformatics pathway analysis [1,2,4,5].
How can CRISPR help study GO:0002764?
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of individual signaling nodes in immune cells [6,8].
Is GO:0002764 a biological process or a molecular function?
GO:0002764 is a biological_process term, meaning it describes a dynamic program rather than a single molecular activity [1,6].
What is the synonym for GO:0002764?
The synonym is immune response-regulating signalling pathway [1,6].
Why is immune response-regulating signaling important for disease research?
Because misregulation of this cascade can drive inflammatory and autoimmune diseases, making it a key target for biomarkers and therapeutics [1,3,8].
Conclusion
GO:0002764 immune response-regulating signaling pathway is a foundational biological_process that connects receptor engagement to immune activation, perpetuation, or inhibition. Its components, from TLR2 and TLR4 to NFKB1 and effector cytokines, are widely studied in infectious, inflammatory, and autoimmune diseases [1,3,6,8]. By combining transcriptomic, single-cell, and CRISPR-based approaches, researchers can move from association to causal mechanism within this pathway. EDITGENE supports this work with knockout, point-mutation, knock-in, overexpression, library screening, and bioinformatics services tailored to immune signaling research [2,5,8].
References
- 1. Sharma N et al.. 2021. Serum-borne lipids amplify TLR-activated inflammatory responses.. J Leukoc Biol 109(4):821-831 PMID: 32717772
- 2. Liu J et al.. 2024. Bioinformatics identifies predictors of arteriovenous fistula maturation.. J Vasc Access 25(1):172-186 PMID: 35686495
- 3. Liang Y et al.. 2024. Deregulation of immune response contributing to fulminant hepatitis in HEV infected pregnant women.. J Med Virol 96(5):e29639 PMID: 38708824
- 4. Altaie AM et al.. 2025. Integrated metagenomics and transcriptomics analysis reveals pathways associated with oral periapical lesions formation and progression.. Curr Res Microb Sci 9:100443 PMID: 40791803
- 5. Serezani APM et al.. 2022. Multiplatform Single-Cell Analysis Identifies Immune Cell Types Enhanced in Pulmonary Fibrosis.. Am J Respir Cell Mol Biol 67(1):50-60 PMID: 35468042
- 6. Yu X et al.. 2014. Navigating through the maze of TLR2 mediated signaling network for better mycobacterium infection control.. Biochimie 102:1-8 PMID: 24594065
- 8. Zhang M et al.. 2025. Genetic architecture of primary biliary cholangitis: strong evidence for HLA and non-HLA risk loci.. Front Immunol 16:1600364 PMID: 40948743
